Newsletter Subject

Wrongful Death Suit Filed After Patient Waited Hours in Emergency Room Lobby

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Oct 13, 2023 10:53 PM

Email Preheader Text

Daily Headlines Friday, October 13, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Friday, October 13, 2023 Today's Top Stories for {NAME} [SPECIAL REPORTS]( [Wrongful Death Suit Filed After Patient Waited Hours in Emergency Room Lobby]( [ONCOLOGY/HEMATOLOGY]( [Study Validates Accuracy of PREDICT Prognostication Tool in Breast Cancer]( [MEETING COVERAGE]( [Kids' Use of Cannabis and Tobacco Rose From 2021 to 2022]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Uncovering the Underlying Cause of Anemia: Making a Myelodysplastic Syndrome Diagnosis]( [EMERGENCY MEDICINE]( [Cryoprecipitate, REBOA Flop for Improving Major Hemorrhage Outcomes]( [MEETING COVERAGE]( [Is It Time to Add Universal CMV Screening for Newborns?]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [SPECIAL REPORTS]( [UNC Health Publicly Threatens to Cancel UnitedHealthcare Contracts]( CME SPOTLIGHT [CAR T-Cell Therapy 101]( [ONCOLOGY/HEMATOLOGY]( [Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout?]( [MEETING COVERAGE]( [Blood Thinners Not a Firm Contraindication for tPA, Study Finds]( [MEETING COVERAGE]( [Medical Tourists Bring Home Fatal Fungal Infections]( CME SPOTLIGHT [Advancing Collaboration Across the Multiple Myeloma Treatment Journey]( [MEETING COVERAGE]( [Cold Temps Tied to More COPD Hospitalizations in Older Adults]( [MEETING COVERAGE]( [ECMO Has Become a Harder Sell in Severe COVID-19]( [PEDIATRICS]( [U.S. Healthcare System Creates Barriers to Vaccine Access, Expert Says]( CME SPOTLIGHT [Hitting the Mark? Targeted Antibody-Based Therapy for Diffuse Large B-Cell Lymphoma]( [PODCASTS]( [MedPod Today: Interpreting COVID Rapid Tests; Medical Meeting Scams; Shadow Work]( [MEETING COVERAGE]( [ITP Drug Shows Benefit in Hospitalized COVID Patients]( [AAD READING ROOM]( [Tapinarof: Clinical and Safety Profile for First-in-Class Psoriasis Drug]( [OPHTHALMOLOGY]( [New Insights Into Ocular Effects of Coronavirus Infection]( [OPINION]( [Did Aerosmith's Steven Tyler Really 'Break His Larynx'?]( [MEETING COVERAGE]( [Novel Drug Shows Promise in Multiple Sclerosis]( [ACR READING ROOM]( [New Insights Into the Pathogenesis of Psoriatic Arthritis]( [ACR READING ROOM]( [Newly Found Dysregulated Immune Cell Profiles in Patients With Psoriatic Arthritis]( [RHEUMATOLOGY]( [CDC: Arthritis Is Massive Public Health Problem]( [GASTROENTEROLOGY]( [New Oral Drug Approved for Ulcerative Colitis in Adults]( [OPINION]( [Healthcare's North Star Should Be Better Health]( [MEDICAL JOURNEYS]( [Helping Atopic Dermatitis Patients Cope With the Condition]( [MEDICAL JOURNEYS]( [For Your Patients: How Atopic Dermatitis Can Affect Your Child's Behavior -- and What to Do]( # Weekly Survey [Are Nurse Staffing Ratios a Good Idea?]( This summer, [Oregon became the second state]( to mandate standards for how many patients a registered nurse can be assigned across a number of hospital units[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-10-13&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.